Logotipo do repositório
 

Publicação:
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation

Página do item simplificado
dc.contributor.authorPerini, Guilherme Fleury
dc.contributor.authorFischer, Thais
dc.contributor.authorGaiolla, Rafael Dezen [UNESP]
dc.contributor.authorRocha, Talita Bueno
dc.contributor.authorBellesso, Marcelo
dc.contributor.authorTeixeira, Larissa Lane Cardoso
dc.contributor.authorDelamain, Marcia Torresan
dc.contributor.authorScheliga, Adriana Alves de Souza
dc.contributor.authorRibeiro, Glaciano Nogueira
dc.contributor.authorNeto, Jorge Vaz
dc.contributor.authorBaiocchi, Otávio Cesar Carvalho Guimaraes
dc.contributor.authorAbdo, André Neder Ramires
dc.contributor.authorArrais-Rodrigues, Celso
dc.contributor.authorFogliatto, Laura M.
dc.contributor.authorBigni, Ricardo de Sá
dc.contributor.authorSchaffel, Rony
dc.contributor.authorBiasoli, Irene
dc.contributor.authorPereira, Juliana
dc.contributor.authorNabhan, Samir Kanaan
dc.contributor.authorSouza, Cármino Antônio de
dc.contributor.authorChiattone, Carlos Sérgio
dc.contributor.institutionHospital Israelita Albert Einstein
dc.contributor.institutionAméricas Oncologia
dc.contributor.institutionAC Camargo Cancer Center
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institution(ICESP)
dc.contributor.institutionHemomed
dc.contributor.institutionHospital Municipal da Vila Santa Catarina
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionGrupo Oncoclínicas - CTO/CEON
dc.contributor.institutionUniversidade Federal de Minas Gerais (UFMG)
dc.contributor.institutionCentro de Cancer de Brasilia CETTRO
dc.contributor.institutionHospital Alemão Oswaldo Cruz
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionHospital Sírio Libanês
dc.contributor.institutionHospital de Clínicas de Porto Alegre (HPCA)
dc.contributor.institutionInstituto Nacional do Cancer (INCA)
dc.contributor.institutionUniversidade Federal do Rio de Janeiro (UFRJ)
dc.contributor.institutionUniversidade Federal do Paraná (UFPR)
dc.contributor.institutionFCM da Santa Casa de São Paulo
dc.contributor.institutionHospital Samaritano Higienópolis
dc.date.accessioned2022-04-29T08:28:37Z
dc.date.available2022-04-29T08:28:37Z
dc.date.issued2020-04-01
dc.description.abstractThe novel Coronavirus (CoVid-19) outbreak is now consider a world pandemic, affecting more than 1,300,000 people worldwide. Cancer patients are in risk for severe disease, including a higher risk of intensive care unit (ICU) admission, need for invasive ventilation or death. Management of patients with lymphoid malignancies can be challenging during the outbreak, due to need of multiple hospital visits and admissions, immunosuppression and need for chemotherapy, radiotherapy and stem cell transplantation. In this article, we will focus on the practical management of patients with lymphoid malignancies during the COVID-19 pandemic, focusing on minimizing the risk for patients.en
dc.description.affiliationHospital Israelita Albert Einstein
dc.description.affiliationAméricas Oncologia
dc.description.affiliationAC Camargo Cancer Center
dc.description.affiliationHospital das Clínicas da Faculdade de Medicina de Botucatu (HC-FMB)
dc.description.affiliationInstituto do Cancer de São Paulo (ICESP)
dc.description.affiliationHemomed
dc.description.affiliationHospital Municipal da Vila Santa Catarina
dc.description.affiliationUniversidade de Campinas (UNICAMP)
dc.description.affiliationGrupo Oncoclínicas - CTO/CEON
dc.description.affiliationHospital das Clínicas da Universidade Federal de Minas Gerais (HC UFMG)
dc.description.affiliationCentro de Cancer de Brasilia CETTRO
dc.description.affiliationHospital Alemão Oswaldo Cruz
dc.description.affiliationUniversidade Federal de São Paulo (Unifesp)
dc.description.affiliationHospital Sírio Libanês
dc.description.affiliationHospital de Clínicas de Porto Alegre (HPCA)
dc.description.affiliationInstituto Nacional do Cancer (INCA)
dc.description.affiliationUniversidade Federal do Rio de Janeiro (UFRJ)
dc.description.affiliationUniversidade Federal do Paraná (UFPR)
dc.description.affiliationFCM da Santa Casa de São Paulo
dc.description.affiliationHospital Samaritano Higienópolis
dc.description.affiliationUnespHospital das Clínicas da Faculdade de Medicina de Botucatu (HC-FMB)
dc.format.extent103-110
dc.identifierhttp://dx.doi.org/10.1016/j.htct.2020.04.002
dc.identifier.citationHematology, Transfusion and Cell Therapy, v. 42, n. 2, p. 103-110, 2020.
dc.identifier.doi10.1016/j.htct.2020.04.002
dc.identifier.issn2531-1387
dc.identifier.issn2531-1379
dc.identifier.scopus2-s2.0-85084136486
dc.identifier.urihttp://hdl.handle.net/11449/228792
dc.language.isoeng
dc.relation.ispartofHematology, Transfusion and Cell Therapy
dc.sourceScopus
dc.subjectChronic lymphocytic leukemia
dc.subjectCoronavirus
dc.subjectCoVid
dc.subjectCoVId-19
dc.subjectLymphoid malignancies
dc.subjectLymphoma
dc.titleHow to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendationen
dc.typeArtigo
dspace.entity.typePublication
unesp.author.orcid0000-0001-7235-1334 0000-0001-7235-1334[1]

Arquivos

Coleções

Botucatu - FMB - Faculdade de Medicina